Wealthcare Advisory Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-40
Closed -$5K 947
2021
Q1
$5K Buy
+40
New +$5.47K ﹤0.01% 1641
2020
Q2
Sell
-20
Closed -$1K 644
2020
Q1
$1K Buy
+20
New +$1.62K ﹤0.01% 1389

Other funds holding EXAS

Wealthcare Advisory Partners's EXAS Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 40 shares — an estimated $5K sold.

Wealthcare Advisory Partners first reported a position in EXAS in Q1 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 40 Exact Sciences shares in Q2 2021, an estimated $5K.
  • Wealthcare Advisory Partners first reported a position in Exact Sciences in Q1 2020 and held it in 2 quarters.
  • Wealthcare Advisory Partners's Exact Sciences position peaked at $5K in Q1 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.